Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

December 2018 - First Report Managed Care Supplement

Department

Managed Care Q&A
12/21/2018

Julie Gould

Julie Gould
Parag Joshi, MD, explains the relevance of the new guidelines on cholesterol management that were presented in November of 2018 at the AHA Scientific Sessions.
Parag Joshi, MD, explains the relevance of the new guidelines on cholesterol management that were presented in November of 2018 at the AHA Scientific Sessions.
Parag Joshi, MD, explains the...
12/21/2018
First Report Managed Care
News Connection
12/21/2018
Recent cardiovascular news including statin safety, cholesterol treatment, and more. 
Recent cardiovascular news including statin safety, cholesterol treatment, and more. 
Recent cardiovascular news...
12/21/2018
First Report Managed Care
Conference Insider
12/21/2018
Highlights from sessions that were held during AHA 2018. 
Highlights from sessions that were held during AHA 2018. 
Highlights from sessions that...
12/21/2018
First Report Managed Care
12/21/2018

Kara Rosania

Kara Rosania
Recent guidance from clinical experts have urged the wider use of genetic testing for familial hypercholesterolemia, given the benefits of early intervention in these patients and the availability of targeted treatments. However, payers must...
Recent guidance from clinical experts have urged the wider use of genetic testing for familial hypercholesterolemia, given the benefits of early intervention in these patients and the availability of targeted treatments. However, payers must...
Recent guidance from clinical...
12/21/2018
First Report Managed Care
12/21/2018

Kara Rosania

Kara Rosania
Payer acceptance of the cholesterol-lowering PCSK9 inhibitors Repatha and Praluent has been limited, due to the high costs of these medications. However, steps by the drugs’ manufacturers, as well as new cardiovascular outcomes data...
Payer acceptance of the cholesterol-lowering PCSK9 inhibitors Repatha and Praluent has been limited, due to the high costs of these medications. However, steps by the drugs’ manufacturers, as well as new cardiovascular outcomes data...
Payer acceptance of the...
12/21/2018
First Report Managed Care

Advertisement

Advertisement

Advertisement